Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A US Multi-center, Prospective, Non-interventional, Long Term, Effectiveness and Safety Study of Patients Treated With SKYTROFA (Lonapegsomatropin)

NCT05820672 is registered in ClinicalTrials.gov with Ascendis Pharma Endocrinology Division A/S as lead sponsor.

NCT NCT05820672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05820672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A US Multi-center, Prospective, Non-interventional, Long Term, Effectiveness and Safety Study of Patients Treated With SKYTROFA (Lonapegsomatropin)
Lead sponsor
Ascendis Pharma Endocrinology Division A/S
Phase
Observational
Overall status
Recruiting
Start date
March 20, 2023
Completion date
March 31, 2033
Enrollment
900 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency